Cell & Gene Therapy Summit 2026

July 6-8, 2026
Wakefield, Massachusetts

The 3rd Global Cell & Gene Therapy Summit, taking place July 6-8, 2026, in Wakefield, MA, brings together industry and academic stakeholders to discuss the evolving landscape of cell and gene therapy research, clinical application, translational science, manufacturing, and commercialization. With a program spanning gene editing, stem cell-based therapies, regenerative medicine, rare diseases, and non-viral delivery strategies, the conference reflects the broad innovation shaping the advanced therapies space.

For cell and gene therapy developers, the meeting addresses many of the challenges that directly affect development planning and clinical execution, including translational strategy, regulatory considerations, and the operational demands of bringing complex therapies into the clinic. These discussions align closely with the need for thoughtful study planning, flexible clinical operations, and reliable execution across highly specialized programs.

PRC Clinical supports cell and gene clinical trials with hands-on operational execution across AAV-based gene therapies, stem cell programs, and studies requiring complex administration and product handling. With experience spanning early feasibility through later-phase clinical trials, PRC helps sponsors navigate the practical demands of specialized study execution while maintaining quality, timelines, and control.

For up-to-date conference information, please visit the conference website linked below. To connect with the PRC Clinical team, fill out the form below.

View the Conference Website